Search

Your search keyword '"Batista, Alzir A."' showing total 65 results

Search Constraints

Start Over You searched for: Author "Batista, Alzir A." Remove constraint Author: "Batista, Alzir A." Topic ruthenium compounds Remove constraint Topic: ruthenium compounds
65 results on '"Batista, Alzir A."'

Search Results

1. Ruthenium(II)-diphosphine complexes containing acylthiourea ligands are effective against lung and breast cancers.

2. Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets.

3. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid.

4. Non-mutagenic Ru(ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding.

5. Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole.

6. Inhibition of human DNA topoisomerase IB by nonmutagenic ruthenium(II)-based compounds with antitumoral activity.

7. A new nitrosyl ruthenium complex: synthesis, chemical characterization, in vitro and in vivo antitumor activities and probable mechanism of action.

8. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes.

10. Ruthenium(II)-diphosphine complexes containing acylthiourea ligands are effective against lung and breast cancers.

11. Ru(II)-Naphthoquinone complexes with high selectivity for triple-negative breast cancer.

12. Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands.

13. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.

14. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I.

15. Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells.

16. Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of Ruthenium(II) Compounds.

17. Spectral and electrochemical studies of ruthenium(II) complexes with N 4-methyl-4-nitrobenzaldehyde and N 4-methyl-4-nitrobenzophenone thiosemicarbazone: Potential anti-trypanosomal agents

18. Synthesis and characterization of [RuCl3(P-P)(H20)] complexes; P-P=achiral or chiral, chelating....

19. Ruthenium(II) complexes with 6-methyl-2-thiouracil selectively reduce cell proliferation, cause DNA double-strand break and trigger caspase-mediated apoptosis through JNK/p38 pathways in human acute promyelocytic leukemia cells.

20. Anti-Proliferative and Anti-Migration Activity of Arene–Ruthenium(II) Complexes with Azole Therapeutic Agents.

21. Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells.

22. Ruthenium complex containing 1,3-thiazolidine-2-thione inhibits hepatic cancer stem cells by suppressing Akt/mTOR signalling and leading to apoptotic and autophagic cell death.

23. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands

24. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells.

25. A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands.

26. An overview on the anticancer activity of Ru(II)/acylthiourea complexes.

27. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes.

28. Ru/Fe bimetallic complexes: Synthesis, characterization, cytotoxicity and study of their interactions with DNA/HSA and human topoisomerase IB.

29. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether).

30. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study.

31. Antitumor and anti-Mycobacterium tuberculosis agents based on cationic ruthenium complexes with amino acids.

32. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway.

33. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.

34. Ru(II)-based complexes with N-(acyl)-N′,N′-(disubstituted)thiourea ligands: Synthesis, characterization, BSA- and DNA-binding studies of new cytotoxic agents against lung and prostate tumour cells.

35. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis.

36. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes.

37. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent.

38. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex.

39. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2

40. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis

41. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes

42. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents

43. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect

44. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents

45. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2 =4,6-dimethyl-2-mercaptopyrimidine

46. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)

47. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands

48. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures

49. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand.

50. Scavenging capacity and cytotoxicity of new Ru(II)-diphosphine/α-amino acid complexes.

Catalog

Books, media, physical & digital resources